Anti-Müllerian Hormone Type II Receptor Expression in Endometrial Cancer Tissue by Marek Gowkielewicz, Aleksandra Lipka, Marta Majewska, Aleksandra Piotrowska, Marta Szadurska-Noga, Jacek J. Nowakowski, Marta Wiszpolska, Piotr Dzięgiel, Tomasz Wasniewski, Mariusz Krzysztof Majewski, Marcin Jozwik

“…No statistical difference was observed for AMHRII expression depending on the histopathological type of EC, cancer staging, body mass index, and age, as well as the number of years of menstruation, births and miscarriages, and average and total breastfeeding time. …”
Get full text

Prognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC) by Karolina Jablonska, Katarzyna Nowinska, Aleksandra Piotrowska, Aleksandra Partynska, Ewa Katnik, Konrad Pawelczyk, Alicja Kmiecik, Natalia Glatzel-Plucinska, Marzenna Podhorska-Okolow, Piotr Dziegiel

“…MT1 immunoexpression decreased as both the tumour size and the cancer stage increased in the whole cohort, while MT2 decreased as the cancer stage increased, with lymph node involvement (in the whole study group) and increasing malignancy grade (in SCC). …”
Get full text

Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer by Katarzyna Ratajczak-Wielgomas, Alicja Kmiecik, Jedrzej Grzegrzołka, Aleksandra Piotrowska, Agnieszka Gomulkiewicz, Aleksandra Partynska, Konrad Pawelczyk, Katarzyna Nowinska, Marzenna Podhorska-Okolow, Piotr Dziegiel

“…POSTN expression in CAFs increased with clinical cancer stage, grades (G) of malignancy, and lymph node involvement in NSCLC. …”
Get full text